Here are comprehensive model answers for your entire Pediatrics First Terminal Examination paper:
DEPARTMENT OF PEDIATRICS - FIRST TERMINAL EXAMINATION (2023 BATCH)
COMPLETE MODEL ANSWERS
SECTION A - LONG ESSAYS (4 x 10 = 40 Marks)
Q1. IMNCI Approach + Assessment, Classification & Management of Cough/Difficulty Breathing
Part 1: IMNCI (Integrated Management of Neonatal and Childhood Illness)
Definition: IMNCI is a WHO/UNICEF strategy for integrated management of sick children aged 0-5 years in first-level health facilities and at community level.
Objectives:
- Reduce under-5 mortality and morbidity
- Improve quality of care at home and health facilities
- Promote healthy growth and development
Components of IMNCI:
- Improvements in case management skills of health workers
- Improvements in overall health system
- Improvements in family and community practices
IMNCI Approach - Steps in Case Management:
- Check for danger signs (general danger signs)
- Assess main symptoms - Cough/difficulty breathing, diarrhea, fever, ear problem
- Check nutritional status - Weight, height, MUAC
- Check immunization and Vitamin A status
- Assess other problems
- Classify illness using color-coded system (Pink/Yellow/Green)
- Identify treatment and treat accordingly
- Counsel mother
General Danger Signs (IMNCI):
- Not able to drink or breastfeed
- Vomiting everything
- Convulsions (present illness)
- Lethargic or unconscious
Part 2: Assessment, Classification & Management of Cough/Difficulty Breathing
Assessment:
- How long has the child had cough?
- Count respiratory rate for 1 full minute
- Look for chest indrawing
- Look and listen for stridor
- Look and listen for wheeze
Age-specific Fast Breathing Thresholds:
| Age | Fast Breathing |
|---|
| < 2 months | ≥ 60 breaths/min |
| 2-12 months | ≥ 50 breaths/min |
| 1-5 years | ≥ 40 breaths/min |
Classification (Color-coded):
| Classification | Signs | Treatment |
|---|
| SEVERE PNEUMONIA (Pink) | Chest indrawing OR stridor in calm child | Refer URGENTLY; give first dose antibiotic (Ampicillin/Benzylpenicillin); treat fever/wheeze |
| PNEUMONIA (Yellow) | Fast breathing ONLY | Oral Amoxicillin x 5 days; soothe throat; follow-up 2 days |
| NO PNEUMONIA - Cough/Cold (Green) | No fast breathing, no chest indrawing | Soothe throat with safe remedy; if >30 days - refer; follow-up 5 days |
Treatment - Pneumonia:
- Amoxicillin: 40 mg/kg/day in 2 divided doses x 5 days
- Cotrimoxazole as alternative
- Treat fever if present (Paracetamol)
- Treat wheeze if present (bronchodilator)
- Advise when to return immediately
Antibiotic for Severe Pneumonia:
- Ampicillin 50 mg/kg IM/IV every 6 hours PLUS Gentamicin 7.5 mg/kg IM/IV once daily
Q2. Protein Energy Malnutrition (PEM) - Definition, SAM Classification, Clinical Features & Management
Definition of PEM
PEM is a spectrum of nutritional disorders resulting from insufficient intake of protein and/or energy to meet physiological needs. It ranges from subclinical deficiency to obvious wasting, stunting, and kwashiorkor.
Types:
- Marasmus - Deficiency of both protein AND calories
- Kwashiorkor - Primarily protein deficiency with adequate caloric intake
- Marasmic-Kwashiorkor - Features of both
Severe Acute Malnutrition (SAM) - Definition
SAM is defined by any one of:
- Weight-for-height/length < -3 SD (Z-score) of WHO median
- MUAC < 115 mm (in 6-59 months)
- Bilateral pitting edema of nutritional origin
- Visible severe wasting
Clinical Features
Marasmus:
- Gross wasting of muscle and subcutaneous fat (skin and bones appearance)
- "Old man face" - sunken cheeks
- Loose, wrinkled skin - "baggy pants" appearance
- Marked weight loss (< 60% of expected)
- Child is alert, hungry, and irritable
- No edema
- Hair changes less prominent
- Voracious appetite
Kwashiorkor:
- Bilateral pitting pedal edema (cardinal feature)
- Moon face (due to edema)
- Flaky paint/crazy pavement dermatosis - skin changes
- Hair changes: depigmentation (reddish/brownish), easily pluckable, "flag sign"
- Hepatomegaly (fatty liver)
- Miserable, anorexic child
- Low serum albumin
- May have adequate weight due to edema (masked wasting)
Management of SAM - Ten Steps (WHO)
Phase 1 - Stabilization (Days 1-7):
- Treat/prevent hypoglycemia - give glucose orally/NG if unconscious; F-75 diet
- Treat/prevent hypothermia - keep warm; Kangaroo mother care
- Treat/prevent dehydration - use ReSoMal (not standard ORS); 5 mL/kg every 30 min for 2 hours
- Correct electrolyte imbalance - K+, Mg²+ supplementation (avoid Na+)
- Treat infection - Broad-spectrum antibiotics (Amoxicillin/Cotrimoxazole); if sick: Ampicillin + Gentamicin
- Correct micronutrient deficiencies - Vit A, folic acid, zinc, copper, multivitamin (NO iron in phase 1)
- Begin cautious feeding - F-75 formula (75 kcal/100 mL); 100 mL/kg/day; every 2-3 hours
Phase 2 - Rehabilitation (Weeks 2-6):
8. Achieve catch-up growth - F-100 (100 kcal/100 mL); increase to 150-220 mL/kg/day
9. Provide sensory stimulation - play therapy, emotional support
10. Prepare for follow-up after recovery
Ready-to-Use Therapeutic Food (RUTF): Plumpy'nut - used in community-based management
Discharge Criteria: MUAC ≥ 125 mm; no edema x 2 consecutive visits; weight-for-height ≥ -2 SD
Q3. Acute Diarrhea - Etiology, Clinical Features, Complications, Management + ORS & Zinc Therapy
Definition
Passage of ≥ 3 loose/watery stools in 24 hours; acute = < 14 days duration
Etiology
Viral (most common):
- Rotavirus (most common cause of severe diarrhea in under-5s)
- Norovirus, Adenovirus, Astrovirus
Bacterial:
- Escherichia coli (ETEC, EPEC, EAEC)
- Shigella dysenteriae - dysentery
- Vibrio cholerae - rice-water stools
- Campylobacter jejuni
- Salmonella species
Parasitic:
- Giardia lamblia
- Entamoeba histolytica - amoebic dysentery
- Cryptosporidium
Clinical Features
- Watery loose stools - frequent (3-10+/day)
- Nausea, vomiting
- Abdominal cramps
- Fever (especially viral/bacterial)
- Signs of dehydration (see Section C)
- Blood/mucus in stools (dysentery - bacterial)
Complications
- Dehydration - most common, life-threatening
- Electrolyte imbalance (hypo/hypernatremia, hypokalemia)
- Metabolic acidosis
- Hypoglycemia (especially in malnourished)
- Acute kidney injury (prerenal)
- Malnutrition (prolonged)
- Intussusception (rare, post-infectious)
- Hemolytic Uremic Syndrome (ETEC/Shigella)
Management (IMNCI - Plan A/B/C)
Plan A (No dehydration):
- Continue breastfeeding
- Give extra fluids (ORS, clean water, soup)
- Continue feeding
- Signs to return immediately
- Zinc supplementation
Plan B (Some dehydration):
- ORS: 75 mL/kg over 4 hours in clinic
- Reassess after 4 hours
- If improved - Plan A; if worsening - Plan C
Plan C (Severe dehydration):
- IV fluids: Ringer's lactate/Normal saline
- < 12 months: 30 mL/kg over 1 hour, then 70 mL/kg over 5 hours
-
12 months: 30 mL/kg over 30 min, then 70 mL/kg over 2.5 hours
- Reassess every 15-30 min
Antibiotics: Only for dysentery (Ciprofloxacin/Azithromycin), cholera (Doxycycline/Azithromycin), Giardia (Metronidazole)
Antidiarrheals: NOT recommended in children
ORS (Oral Rehydration Solution)
WHO Low-Osmolarity ORS Composition (2002):
| Component | Amount |
|---|
| Sodium chloride | 2.6 g/L |
| Glucose (anhydrous) | 13.5 g/L |
| Potassium chloride | 1.5 g/L |
| Trisodium citrate | 2.9 g/L |
| Osmolarity | 245 mOsm/L |
| Sodium | 75 mEq/L |
| Chloride | 65 mEq/L |
| Glucose | 75 mmol/L |
| Potassium | 20 mEq/L |
| Citrate | 10 mEq/L |
Mechanism: Glucose-coupled sodium cotransport (SGLT1) drives water absorption even during active secretion.
ReSoMal (for SAM): Lower sodium (45 mEq/L), higher potassium, lower osmolarity (300 mOsm/L)
Zinc Therapy
Rationale: Zinc deficiency is common in malnourished children; zinc reduces stool frequency and duration.
Dose:
- < 6 months: 10 mg/day x 14 days
- ≥ 6 months: 20 mg/day x 14 days
Benefits:
- Reduces duration of diarrhea by ~25%
- Reduces severity (stool frequency and volume)
- Prevents subsequent episodes for 2-3 months
- Reduces risk of progression to persistent diarrhea
Q4. Measles - Etiology, Clinical Features, Diagnosis, Complications & Management
Etiology
- Causative agent: Measles virus - RNA virus, paramyxovirus family (genus Morbillivirus)
- Transmission: Droplet infection; highly contagious (R₀ = 12-18)
- Incubation period: 10-14 days (range 7-18 days)
- Infectious period: 4 days before to 4 days after rash appearance
- Epidemic pattern: Winter-spring; 2-yearly cycles
Clinical Features
Prodromal Stage (Day 1-4):
- High fever (38-40°C)
- Coryza (runny nose)
- Cough (barking)
- Conjunctivitis (3 Cs: Cough, Coryza, Conjunctivitis)
- Koplik's spots (pathognomonic) - Appear on Day 2-3; salt/sand grains on a red base on buccal mucosa opposite lower molars; disappear 1-2 days after rash
Eruptive Stage (Day 4 onwards):
- Rash: Maculopapular, starts behind ears/hairline; spreads downward (cephalocaudal) over 3 days: face → trunk → limbs
- Fever peaks with rash, then falls
- Rash lasts 4-7 days; fades in same order it appeared
- Post-measles desquamation and brownish staining
Diagnosis
- Mainly clinical (Koplik's spots + typical rash)
- Serology: IgM antibody (positive 3-4 days after rash onset) - confirmatory
- Viral isolation/PCR (epidemiological purposes)
Complications
Respiratory:
- Pneumonia (most common cause of death) - measles giant cell pneumonitis, secondary bacterial pneumonia
- Croup (laryngitis)
- Otitis media (most common complication overall)
Neurological:
- Acute post-measles encephalitis (1/1000 cases) - day 2-5 after rash
- Febrile seizures
- Subacute sclerosing panencephalitis (SSPE) - rare, fatal; 7-10 years after infection; caused by defective measles virus
Others:
- Diarrhea and vomiting
- Keratoconjunctivitis → corneal ulceration → blindness (especially with Vit A deficiency)
- Cancrum oris (noma) - in severely malnourished
- Myocarditis, hepatitis (rare)
Management
Supportive:
- Antipyretics (Paracetamol)
- Adequate hydration and nutrition
- Continue breastfeeding
Vitamin A: (Reduces mortality by 50%)
- < 6 months: 50,000 IU single dose
- 6-12 months: 100,000 IU single dose
-
12 months: 200,000 IU single dose
- Repeat if signs of Vit A deficiency (xerophthalmia)
Antibiotics: Only if secondary bacterial infection (otitis media, pneumonia)
Complications: Treat accordingly
Prevention:
- MMR vaccine at 9 months (NIS - India: MR at 9-12 months) and 15-18 months booster
- Post-exposure prophylaxis: Vaccine within 72 hours OR immunoglobulin within 6 days
SECTION B - SHORT ESSAYS (6 x 5 = 30 Marks)
B-Q1. National Immunization Schedule (NIS) - India
| Vaccine | Age | Route/Site | Dose |
|---|
| BCG + OPV-0 + Hep B-1 | Birth | ID (right arm) / Oral / IM | 0.1 mL / 2 drops / 0.5 mL |
| OPV-1 + Pentavalent-1 + RVV-1 + fIPV-1 | 6 weeks | Oral / IM (left thigh) / Oral / ID (right arm) | |
| OPV-2 + Pentavalent-2 + RVV-2 | 10 weeks | | |
| OPV-3 + Pentavalent-3 + fIPV-2 + RVV-3 | 14 weeks | | |
| MR-1 + PCV-1 + JE-1 (endemic areas) | 9-12 months | SC / IM / SC | 0.5 mL each |
| MR-2 + DPT-B1 + OPV-B1 + PCV-B + JE-2 + Vitamin A (1st dose) | 16-24 months | | |
| DPT-B2 + OPV-B2 + Vitamin A (2nd-9th dose) | 5-6 years | IM / Oral | Every 6 months |
| Td | 10 years, 16 years | IM | 0.5 mL |
| TT/Td | Pregnancy (TT-1, TT-2/Booster) | IM | 0.5 mL |
Pentavalent = DPT + Hep B + Hib
Cold chain: Vaccines require 2-8°C storage (except OPV: -15 to -25°C; BCG: 2-8°C)
B-Q2. Breastfeeding - Advantages and Exclusive Breastfeeding
Definition of Exclusive Breastfeeding (EBF)
Feeding only breast milk - no other food, water, or liquid (except medications/vitamins/minerals) for the first 6 months of life.
Advantages of Breastfeeding
For Infant:
- Nutritional: Perfect composition; bioavailability of iron, zinc, calcium superior; composition changes with infant's needs
- Immunological: IgA (secretory), lactoferrin, lysozyme, macrophages - protection against infections
- Reduces incidence/severity of diarrhea, pneumonia, otitis media, UTI, meningitis
- Reduces risk of SIDS, childhood obesity, type 1 DM, allergies, leukemia
- Promotes bonding, cognitive development (DHA in breast milk)
- Perfect temperature, sterile, convenient, no preparation
For Mother:
- Uterine involution (oxytocin release) - reduces postpartum hemorrhage
- Lactational amenorrhea - natural contraception (LAM: <6 months, EBF, amenorrheic = 98% effective)
- Reduced risk of breast and ovarian cancer
- Faster return to pre-pregnancy weight (burns ~500 kcal/day)
- Psychological bonding/satisfaction
- Cost-effective (no formula cost)
WHO Recommendation: EBF for 6 months, then complementary feeding with continued breastfeeding up to 2 years or beyond.
Contraindications to Breastfeeding:
- HIV positive mother (in developed countries)
- Active untreated tuberculosis
- Galactosemia (infant)
- Maternal chemotherapy/radiotherapy
- Herpes simplex lesions on nipple
B-Q3. Vitamin A Deficiency - Clinical Features and Prevention
Vitamin A Deficiency (VAD)
Causes: Inadequate dietary intake, malabsorption (fat malabsorption), measles (precipitant), protein deficiency
Clinical Features - Bitot's WHO Classification (XN to XF)
| Stage | Features |
|---|
| XN | Night blindness (nyctalopia) - earliest symptom |
| X1A | Conjunctival xerosis (dry, lustreless conjunctiva) |
| X1B | Bitot's spots - Triangular, foamy/cheesy plaques on temporal conjunctiva (pathognomonic) |
| X2 | Corneal xerosis - hazy, lustreless cornea |
| X3A | Corneal ulceration < 1/3 corneal surface |
| X3B | Keratomalacia - ulceration > 1/3 corneal surface; total liquefaction → blindness (most severe) |
| XF | Xerophthalmia fundus - white dots peripheral retina |
| XS | Corneal scar (sequela) |
Systemic features:
- Follicular hyperkeratosis (toad skin)
- Increased susceptibility to infections (measles, diarrhea, respiratory)
- Growth retardation
- Anemia (impairs iron utilization)
Prevention
Dietary: Dark green leafy vegetables, yellow/orange fruits (mango, papaya), egg yolk, liver, milk, fish
National Vitamin A Supplementation Programme (India):
- 9-12 months: 1st dose with MR vaccine - 1 lakh IU
- 16-24 months to 5 years: 2 lakh IU every 6 months (total 9 doses)
Treatment:
- Day 1, Day 2, Day 8 (or 4 weeks later) - age-specific doses
-
12 months: 200,000 IU per dose
Fortification: Fortify edible oils, sugar, milk with Vitamin A
B-Q4. Rickets - Etiology, Clinical Features and Treatment
Definition
Failure of mineralization of growing bone/osteoid at the growth plate due to deficiency of Vitamin D, calcium, or phosphorus.
Etiology
Nutritional Rickets (most common):
- Vitamin D deficiency (dietary lack + inadequate sunlight)
- Calcium deficiency rickets (common in Africa/India - low calcium diet)
Malabsorption: Celiac disease, inflammatory bowel disease, cholestatic liver disease
Renal Rickets: Chronic kidney disease (renal osteodystrophy), Fanconi syndrome
Vitamin D-dependent Rickets (VDDR): Type I (1-alpha hydroxylase deficiency), Type II (receptor defect)
Hypophosphatemic Rickets (X-linked): Phosphate wasting at renal tubule
Clinical Features
Skeletal:
- Craniotabes - softening of skull bones (earliest sign, <6 months)
- Delayed anterior fontanelle closure
- Frontal bossing (hot cross bun skull)
- Rachitic rosary - beading of costochondral junctions
- Harrison's sulcus - horizontal groove on lower chest (pull of diaphragm)
- Pigeon chest (pectus carinatum) or Harrison's groove
- Bow legs (genu varum) - most common; or knock knees (genu valgum) after walking
- Metaphyseal widening - wrist widening (most common clinical site seen)
- Delayed teething, enamel defects
- Short stature
Non-skeletal:
- Hypocalcemic features: Tetany, seizures, stridor (laryngospasm), Chvostek's sign, Trousseau's sign
- Hypotonia, pot belly
- Anemia, susceptibility to infections
Investigations
- X-ray wrist: Cupping, fraying, splaying of metaphysis; widened growth plate (most characteristic)
- Serum 25-OHD3 < 20 ng/mL (deficiency), < 12 ng/mL (severe)
- Low/normal calcium, low phosphorus, elevated ALP (markedly)
- PTH elevated (secondary hyperparathyroidism)
Treatment
Vitamin D deficiency rickets:
- Stoss therapy: Single oral dose of 3-6 lakh IU Vitamin D - preferred
- Daily therapy: 2000-4000 IU/day for 3 months
- Calcium supplementation: 500-1000 mg/day
- Adequate sunlight (30 min/day of face/arm exposure)
Monitoring: X-ray, ALP at 3 months (healing: ALP normalizes first)
Hypophosphatemic rickets: Phosphate + calcitriol supplementation
B-Q5. Dengue Fever - Warning Signs and Management
Dengue Fever
Causative agent: Dengue virus (DENV 1-4) - Flavivirus; transmitted by Aedes aegypti mosquito
WHO 2009 Classification
- Dengue without warning signs
- Dengue with warning signs
- Severe dengue
Warning Signs (W in Dengue)
Appear during defervescence (day 3-7), as fever resolves:
- Abdominal pain - severe, continuous
- Persistent vomiting (≥ 3 in 24 hours)
- Clinical fluid accumulation - pleural effusion, ascites
- Mucosal bleed - gum bleeding, epistaxis
- Lethargy/restlessness
- Liver enlargement > 2 cm
- Rise in HCT with rapid decrease in platelet count
Severe Dengue (any one):
- Severe plasma leakage → dengue shock syndrome (DSS) → circulatory failure
- Severe bleeding
- Severe organ involvement (liver: AST/ALT ≥ 1000, CNS: altered consciousness, heart, kidneys)
Management
Group A (Dengue without warning signs - outpatient):
- Adequate oral hydration (ORS, coconut water, juice)
- Paracetamol (NOT aspirin or ibuprofen - risk of bleeding)
- Antipyretics, mosquito net
- Daily monitoring
Group B (Dengue with warning signs - hospitalize):
- IV crystalloids (NS/RL): 5-10 mL/kg/hour initially
- Titrate based on clinical response; monitor HCT, urine output
- Platelet transfusion: Only if < 10,000/µL (no active bleeding) or < 20,000/µL with bleeding
- Monitor every 1-2 hours
Group C (Severe dengue - ICU):
- IV fluid resuscitation: 20 mL/kg bolus over 15-30 min
- Colloids (gelatin/dextran) if HCT still rising despite crystalloids
- Blood transfusion for severe hemorrhage
- Vasopressors if refractory shock
- Organ support as needed
No specific antiviral therapy available.
B-Q6. Rules of Development and Factors Affecting Development
Normal Development - Key Rules
- Cephalocaudal progression - Head control before sitting before standing
- Proximal to distal - Shoulder control before hand, hand before finger grasp
- General to specific - Mass movements before fine movements
- Sequential and predictable - Fixed sequence (though rate varies)
- Continuous process - Never stops throughout life
- Rate varies between children - Normal variation exists around milestones
- Bilateral to unilateral - Bilateral movements before dominant hand preference
- Integration of primitive reflexes allows voluntary movements
- Development reflects maturation of CNS - myelination pattern
Key Developmental Milestones (Summary)
| Age | Gross Motor | Fine Motor | Language | Social |
|---|
| 3 months | Head control | Open fists | Coos | Social smile |
| 6 months | Sits with support | Palmar grasp | Babbles | Stranger anxiety begins |
| 9 months | Sits without support | Pincer (immature) | Mama/Dada (non-specific) | Peek-a-boo |
| 12 months | Walks with support | Mature pincer | 1 word with meaning | Waves bye |
| 18 months | Walks well | Scribbles | 10 words | Points to wants |
| 2 years | Runs, up stairs | Tower of 6 cubes | 2-word sentences | Parallel play |
| 3 years | Tricycle | Tower of 9, copies circle | 3-word sentences, 900 words | Group play |
| 5 years | Skips | Ties shoelace, copies triangle | Fluent speech | Cooperative play |
Factors Affecting Development
Biological/Intrinsic Factors:
- Genetics/heredity
- Gestational age (prematurity)
- Birth weight
- Nutrition (especially first 1000 days)
- Hormones (thyroid, growth hormone)
- Sensory integrity (hearing, vision)
- CNS integrity (birth asphyxia, meningitis, trauma)
Environmental/Extrinsic Factors:
- Socioeconomic status
- Parental education and stimulation
- Quality of caregiver interaction (attachment)
- Play opportunities and toys
- School and peer influence
- Infections, toxin exposure (lead)
- Psychosocial adversity, abuse, neglect
SECTION C - SHORT ANSWERS (10 x 3 = 30 Marks)
C-Q1. DANGER Signs in a Sick Child (IMNCI General Danger Signs)
- Not able to drink or breastfeed
- Vomits everything
- History of convulsions during present illness
- Lethargic or unconscious
Plus age-specific signs for young infant (< 2 months):
- Axillary temperature < 35.5°C or > 37.5°C
- Severe chest indrawing
- Nasal flaring
- Bulging fontanelle
- Umbilical discharge/redness extending to skin
Any general danger sign = Refer URGENTLY to hospital
C-Q2. Fever with Rash
| Condition | Rash Character | Distribution | Key Feature |
|---|
| Measles | Maculopapular, red | Cephalocaudal (face→feet) | Koplik's spots, 3 Cs |
| Rubella | Fine maculopapular, pink | Face→trunk→limbs (faster, 3 days) | Forchheimer spots, posterior cervical LAP |
| Chickenpox | Vesicular - "dewdrop on rose petal" | Centripetal (trunk more than limbs) | All stages simultaneously, pruritic |
| Roseola Infantum (HHV-6) | Macular, rose-colored | Trunk → limbs | Rash AFTER fever resolves (rose spots) |
| Scarlet Fever | Sandpaper rash, erythematous | Neck→trunk (spares face) | Circumoral pallor, strawberry tongue |
| Dengue | Maculopapular + petechiae | Trunk; Islands of white in sea of red | Tourniquet test positive |
| Meningococcemia | Petechiae/purpura, non-blanching | Widespread | Rapidly progressing - EMERGENCY |
| Typhoid | Rose spots (2-4 mm) | Trunk | 7-10 day fever before rash |
| Kawasaki | Polymorphous | Trunk, perineum | Fever > 5 days + 4/5 criteria |
C-Q3. Types of Vaccines
Based on Composition:
1. Live Attenuated Vaccines:
- Weakened live organism
- Single dose usually sufficient; produces cellular + humoral immunity
- Examples: BCG, OPV, MMR, Varicella, Yellow Fever, Rotavirus
- Contraindicated in immunocompromised
2. Killed/Inactivated Vaccines:
- Whole killed organism
- Multiple doses needed; less durable immunity
- Examples: IPV (Salk), Hepatitis A, Rabies, Pertussis (whole cell), JE
3. Toxoid Vaccines:
- Inactivated bacterial toxin
- Examples: Diphtheria toxoid, Tetanus toxoid (DT, Td, TT)
4. Subunit/Acellular Vaccines:
- Purified antigen component
- Examples: Acellular pertussis (DTaP), Hepatitis B (surface antigen), Typhoid Vi polysaccharide
5. Conjugate Vaccines:
- Polysaccharide antigen linked to protein carrier → T-dependent response
- Examples: Hib, Pneumococcal (PCV), Meningococcal
6. Recombinant Vaccines:
- Produced by genetic engineering
- Example: Hepatitis B (HBsAg in yeast)
7. mRNA Vaccines:
- Example: COVID-19 vaccines (Pfizer-BioNTech, Moderna)
C-Q4. Signs of Dehydration
| Feature | No Dehydration | Some Dehydration | Severe Dehydration |
|---|
| General condition | Well, alert | Restless, irritable | Lethargic/unconscious |
| Eyes | Normal | Sunken | Very sunken, dry |
| Tears | Present | Absent | Absent |
| Mouth/tongue | Moist | Dry | Very dry |
| Thirst | Drinks normally | Thirsty, drinks eagerly | Drinks poorly/not at all |
| Skin pinch | Goes back immediately | Goes back slowly (< 2 sec) | Goes back very slowly (> 2 sec) |
| Fontanelle | Normal | Slightly sunken | Markedly sunken |
| Urine | Normal | Decreased, concentrated | Oliguria/anuria |
| Pulse | Normal | Slightly rapid | Rapid, feeble or impalpable |
| BP | Normal | Normal/low | Hypotension |
| % Fluid deficit | < 5% | 5-9% | ≥ 10% |
C-Q5. ORS Composition
WHO Low-Osmolarity ORS (2002 - currently recommended):
| Component | Concentration (mmol/L) | Grams/Litre |
|---|
| Sodium | 75 | - |
| Chloride | 65 | NaCl: 2.6 g |
| Glucose (anhydrous) | 75 | 13.5 g |
| Potassium | 20 | KCl: 1.5 g |
| Citrate | 10 | Sodium citrate: 2.9 g |
| Total osmolarity | 245 mOsm/L | - |
How to prepare: Dissolve one ORS sachet in 1 litre of clean water
Advantages of reduced-osmolarity ORS over old ORS (311 mOsm/L):
- Less stool output
- Less vomiting
- Reduced need for IV therapy
- Safer in children
C-Q6. Difference Between Marasmus and Kwashiorkor
| Feature | Marasmus | Kwashiorkor |
|---|
| Definition | Deficiency of protein + calories | Primarily protein deficiency |
| Age | < 1 year (infants) | 1-3 years (toddlers) |
| Cause | Starvation (early weaning, no breastfeeding) | Protein-poor diet (after weaning on starchy food) |
| Weight | < 60% expected; markedly reduced | 60-80% expected; may be normal (edema masks) |
| Edema | Absent | Present (bilateral, pitting, pedal) |
| Face | Old man face, sunken cheeks | Moon face (edema) |
| Muscle | Grossly wasted | Wasted (masked by edema) |
| Subcutaneous fat | Absent | Present (variable) |
| Skin | Loose, wrinkled, baggy pants | Flaky paint dermatosis, hyperpigmentation |
| Hair | Sparse, thin | Depigmented, easily pluckable, flag sign |
| Liver | Normal | Hepatomegaly (fatty liver) |
| Appetite | Voracious (hungry) | Anorexic, miserable |
| Mood | Alert, irritable | Apathetic, miserable |
| Serum albumin | Low-normal | Very low |
| Prognosis | Better | Worse (more complications) |
C-Q7. Triad of Congenital Rubella Syndrome (Gregg's Triad)
Gregg's Triad:
- Congenital Heart Disease - Patent Ductus Arteriosus (PDA) most common; also pulmonary artery stenosis, VSD, ASD
- Congenital Cataracts - "Salt and pepper" retinopathy; may have glaucoma; "pearly white" lens opacity
- Sensorineural Hearing Loss - Most common single defect; bilateral, often severe
Additional features of Congenital Rubella Syndrome (CRS):
- Blueberry muffin spots (dermal hematopoiesis)
- Microcephaly, mental retardation
- Thrombocytopenic purpura
- Hepatosplenomegaly
- Growth retardation
- Diabetes mellitus (late)
- Thyroid dysfunction (late)
Risk of CRS: Highest if maternal infection in first trimester (up to 85% risk in first 8 weeks)
Prevention: MMR vaccination before pregnancy; rubella IgM serology in early pregnancy
C-Q8. Complications of Diphtheria
Causative agent: Corynebacterium diphtheriae (toxin-mediated disease)
Complications (Local and Systemic):
Respiratory/Local:
- Airway obstruction - most common cause of death; membrane spreads to larynx → "bull neck", croup, stridor
- Aspiration pneumonia
- Tracheitis, bronchitis
Cardiovascular (Myocarditis):
- Most important cause of death (late complication, weeks 2-3)
- ECG: ST changes, heart block (all degrees), ventricular arrhythmias, complete AV block
- Myocarditis occurs in 10-25% of cases
- Dilated cardiomyopathy, heart failure
Neurological:
- Palatal palsy - earliest, 1-2 weeks (nasal twang, regurgitation)
- Oculomotor palsy - diplopia, blurred vision, ptosis (3-5 weeks)
- Peripheral neuropathy - ascending polyneuropathy, months after illness (Guillain-Barré like)
- Phrenic nerve palsy → diaphragmatic paralysis → respiratory failure
Other:
- Thrombocytopenia
- Renal tubular necrosis
- Adrenal hemorrhage
C-Q9. Define Cold Chain
Cold Chain is the system of transporting and storing vaccines at the manufacturer-recommended temperature (2-8°C for most vaccines) from the point of manufacture to the point of administration to maintain potency (viability) of vaccines.
Components of Cold Chain:
- Cold chain equipment:
- ILR (Ice-lined refrigerators) - District/PHC level
- Deep freezer (-15 to -25°C) - for OPV storage
- Cold boxes - for transportation
- Vaccine carriers - for last mile (field level)
- Ice packs
-
Cold chain personnel: Trained handlers at each level
-
Cold chain transportation: Insulated vans, cold boxes
-
Cold chain monitoring:
- VVM (Vaccine Vial Monitor) - heat-sensitive label on vial; inner square becomes darker than outer ring when vaccine is heat-damaged
- Thermometer logs
- Shake test (for freeze-sensitive vaccines like DPT, Hep B, TT)
Cold Chain Levels in India:
- National/Regional: Vaccine manufacturers → national stores
- State → District (ILR + deep freezer)
- Taluk/Block (PHC) - ILR + deep freezer
- Sub-centre/field - vaccine carrier with ice packs
"Open Vial Policy": Multi-dose vials (OPV, BCG, Measles) can be reused at subsequent sessions if stored at 2-8°C
C-Q10. Causes of Iron Deficiency Anemia (IDA)
Most common cause of anemia worldwide, especially in children 6 months-2 years
Causes:
1. Inadequate Intake:
- Exclusive breastfeeding beyond 6 months without complementary foods
- Cow's milk diet (low iron, high calcium blocks absorption)
- Poor weaning diet (cereal-based, low meat/flesh foods)
- Poverty, food insecurity
2. Increased Demand:
- Prematurity/low birth weight (reduced iron stores at birth)
- Rapid growth (infancy, adolescence)
- Twin pregnancy
3. Decreased Absorption:
- Malabsorption syndromes (celiac disease, short bowel)
- Achlorhydria (reduced ferric → ferrous conversion)
- Inhibitors in diet: phytates (cereals), tannins (tea), calcium (dairy) - taken with iron
- Helicobacter pylori infection (reduces absorption)
4. Increased Loss:
- Chronic blood loss: Hookworm infestation (most common cause in older children/adults in India)
- Meckel's diverticulum, intestinal polyps
- Cow's milk protein-induced enteropathy (occult blood loss)
- Inflammatory bowel disease
- Repeated phlebotomy
5. Perinatal Causes:
- Early cord clamping (reduces iron transfer)
- Feto-maternal hemorrhage
- Small for gestational age
Investigation: Blood picture (microcytic hypochromic), low serum ferritin (most sensitive), low serum iron, raised TIBC, low transferrin saturation, low reticulocyte count
All answers are based on standard pediatric references including Nelson's Textbook of Pediatrics, IAP Textbook of Pediatrics, WHO/UNICEF IMNCI guidelines, and National Health Mission (India) protocols.